Generics Industry News Search
 |
|
|
|
|
|
|
January 2012 News Archive |
|
|
| |
|
Actavis has begun shipping Clobetasol propionate shampoo and Clobetasol propionate lotion, generic equivalents to Galderma's Clobex shampoo and Clobex topical lotion...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Regeneron pharmaceuticals today announced that the company has entered into a non-exclusive license and partial settlement agreement with Genentech, a member of the Roche Group relating to U.S. ophthalmic sales of Eylea (aflibercept) injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly & Co. sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system diseases...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today confirmed that the company has been sued by Takeda Pharmaceutical Company, Watson Pharmaceuticals and Andrx Labs in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Pioglitazone Hydrochloride and Extended-release Metformin Hydrochloride tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced enrollment of the first patient in a Phase III U.S. clinical program for its biosimilar erythropoietin...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration for marketing 50 mcg nasal spray of Fluticasone which is used in treatment of allergic rhinitis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Biologics drug development and manufacturing services provider Omnia Biologics today announced that its customer Sumagen will begin clinical trials of their revolutionary HIV vaccine design...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amerigen and the Fosun Omni today announced they had entered into a collaboration agreement regarding the development of generic oral controlled release products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amerigen Pharmaceuticals Limited and VIWA Pharmaceutical Company Limited today jointly announce the signing of a memorandum of understanding (MOU) setting out their intention to establish a joint venture to develop and register a range of branded generic medicines for sale in China...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Prasco Laboratories announced today it has entered into an agreement with Shire for the distribution in the U.S. of the authorized generic version of Carbatrol (Carbamazepine) extended-release capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company announced today that the United States District Court for the Western District of Michigan has granted summary judgment in its favour in patent litigation involving Guaifenesin extended-release tablets, a generic version of Mucinex tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
As a large number of branded biopharmaceuticals/biologics are slated to lose patent protection in the US and other markets, generic companies like Hospira, Inc., Teva Pharmaceuticals and Sandoz, the generic arm of Novartis, are stepping up their R&D; expenses to manufacture biosimilars/biogenerics which are cheaper generic alternatives to expensive biopharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Alnylam Pharmaceuticals has fired the latest round - this time in federal court - in an ongoing patent feud with development partner Tekmira Pharmaceuticals over siRNA and lipid nanoparticle drug delivery technology...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced wednesday that its subsidiary Teva UK would be launching the generic version of Latanoprost eye drops for the treatment of glaucoma...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Pharma, Inc. has launched Vestura, a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Yaz oral contraceptive product...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL, 1000 mg/100 mL and 1500 mg/100 mL, for intravenous use...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics Inc., USA, a subsidiary of Glenmark Generics Ltd, today announced they have been granted final approval for two abbreviated new drug applications by the United States Food and Drug Administration...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Medicines Company today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application filed by APP Pharmaceuticals, LLC for a generic version of Angiomax...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for Azelastine hydrochloride nasal spray and has notified Meda Pharmaceuticals, the owner of the New Drug Application of its filing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Depomed, today announced that it has received a Paragraph IV certification notice from Actavis advising Depomed that Actavis has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market a generic version of Gralise (Gabapentin), 300 mg and 600 mg tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, announced that it has acquired Ascent Pharmahealth, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab, for AU$375 million in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis Group has launched Latanoprost eye drops in seven major European markets, immediately after the patents expired in January...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Three plaintiffs filed a complaint against defendant, Macoven Pharmaceuticals, for patent infringement and false advertising...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc., today confirmed that the United States Court of Appeals for the Federal Circuit has granted Watson and Amphastar Pharmaceuticals, Inc's request for a stay of the preliminary injunction preventing the companies from marketing or selling Amphastar's Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' Lovenox...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc.- Florida has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Watson's generic versions of Mallinckrodt's Exalgo (Hydromorphone Hydrochloride Extended-Release ) tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for Lorazepam oral concentrate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDA) for Phentermine HCl capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The European Commission has issued a formal request to Italy to remove linkage between patents and generic medicines authorisation that it says is causing delays in generics reaching the market...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
